REAL-WORLD DATA ANALYSIS OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) TREATMENT DECISIONS WITH THE INTRODUCTION OF NEWER TREATMENT OPTIONS

被引：0
|
作者：
Scott, J. [1 ]
Concepcion, R. [1 ]
Garofalo, D. [1 ]
Verma-Kurvari, S. [1 ]
Xu, B. [1 ]
Montgomery, J. [1 ]
机构：
[1] Integra Connect, W Palm Beach, FL USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.246
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN199
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [41] Real-world genetic testing patterns in metastatic castration-resistant prostate cancer
    Shore, Neal
    Ionescu-Ittu, Raluca
    Yang, Lingfeng
    Laliberte, Francois
    Mahendran, Malena
    Lejeune, Dominique
    Yu, Louise
    Burgents, Joseph
    Duh, Mei Sheng
    Ghate, Sameer R.
    FUTURE ONCOLOGY, 2021, 17 (22) : 2907 - 2921
  • [42] Real-world treatment patterns in French metastatic castration-resistant prostate cancer patients under abiraterone or enzalutamide
    Scailteux, L. M.
    Vincendeau, S.
    Gravis, G.
    Mathieu, R.
    Balusson, F.
    Kerbrat, S.
    Oger, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 10 - 11
  • [43] Efficacy of Novel Hormone Agents in the Treatment of Metastatic Castration-resistant Prostate Cancer: A Real-world Retrospective Study
    LI, Jian-ri
    Wang, Shian-shiang
    Chen, Chuan-shu
    Yang, Cheng-kuang
    Lu, K. E. V. I. N.
    Cheng, Chen-Li
    Hung, Sheng-Chun
    Chen, Shu-Yen
    Hsu, Chiann Yi
    Chiu, Kun-Yuan
    ANTICANCER RESEARCH, 2022, 42 (10) : 4857 - 4866
  • [44] REAL-WORLD EFFECTIVENESS AND TREATMENT ADHERENCE OF APALUTAMIDE IN NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS
    Lowentritt, Benjamin
    Brown, Gordon
    Kernen, Kenneth
    Pilon, Dominic
    Ellis, Lorie
    Germain, Guillaume
    Rossi, Carmine
    Lefebvre, Patrick
    Sieber, Paul
    Shore, Neal
    JOURNAL OF UROLOGY, 2021, 206 : E58 - E58
  • [45] Real-world treatment (Tx) patterns in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair mutations (HRRm plus )
    Shore, N.
    Ionescu-Ittu, R.
    Laliberte, F.
    Yang, L.
    Gayle, A.
    Payne, S.
    Mahendran, M.
    Amin, S.
    Lejeune, D.
    Burgents, J. E.
    Duh, M. S.
    Yu, L.
    Ghate, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S531 - S532
  • [46] Treatment patterns and survival in men with metastatic castration-resistant prostate cancer (mCRPC): A systematic literature review of 35 real-world observational studies.
    Raval, Amit D.
    Queen, V. Viji
    Korn, Matthew J.
    Quintero, Vanessa
    Freedland, Stephen J.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [47] Treatment patterns and outcomes for metastatic castration-resistant prostate cancer (mCRPC) in a real-world setting: A retrospective study of greater than 2500 patients.
    Higano, Celestia S.
    Sternberg, Cora N.
    Saad, Fred
    Tombal, Bertrand F.
    Miller, Kurt
    Kalinovsky, Jan
    Jiao, XiaoLong
    Tangirala, Krishna
    Sartor, A. Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [48] REAL-WORLD TREATMENT PATTERNS AND CARE PATHWAYS IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER
    Lam, J.
    Yang, C.
    Kaiser, C.
    Wong, W.
    VALUE IN HEALTH, 2018, 21 : S41 - S41
  • [49] New Treatment Options in Castration-Resistant Prostate Cancer
    Armstrong, Andrew J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (5.5): : 690 - 693
  • [50] REAL-WORLD TREATMENT SEQUENCING OF ABIRATERONE AND ENZALUTAMIDE IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC): WHAT ARE THE HEALTH ECONOMIC IMPLICATIONS?
    Pereira-Salgado, A.
    Tran, B.
    Kwan, E.
    Angelyn, A.
    Gibbs, P.
    IJzerman, M. J.
    VALUE IN HEALTH, 2019, 22 : S460 - S460
12345